(DIR) Home
        
        
       Weight loss drug Wegovy now available in Canada
        
 (HTM) Source
        
       ----------------------------------------------------------------------
        
       Canadians struggling with obesity have another option at the pharmacy.
        
       Wegovy, from the company behind Ozempic, is now available across
       Canada.
        
       In Brantford, Ont., pharmacist Ramez Girgis has been helping customer
       Yvette with her weight loss journey.
        
       "I was on Ozempic," she explained to CTV News. "However, it was
       recommended that I go over to Wegovy because it's covered by my health
       insurance."
        
       She came into Guardian Discount Pharmacy on Wednesday to pick a
       different prescription when Girgis let her know the drug was now in
       stock.
        
       "This is terrific for me, to assist in getting my health back," Yvette
       explained.
        
       She's not alone.
        
       "We, at Guardian, started two patients on Wegovy already. Their
       insurance covered it," Girgis said.
        
       There's been so much interest in the drug that he's been fielding
       calls from curious customers before it was even available in Canada.
        
       Wegovy is an injectable drug that people take on a weekly basis. It
       contains the same medication as Ozempic - semaglutide.
        
       "It works by sending a message to your brain, to let the brain know:
       'I am full, I don't need any more food,'" explained Girgis.
        
       But there are differences between the two drugs. Wegovy, unlike
       Ozempic, was specifically created to help people who meet a certain
       criteria related to their weight.
        
       "The patient's body mass index has to be 27, with a co-morbid chronic
       medical condition - diabetes, hypertension, whatnot," Girgis said.
       "The other thing is, if the patient's body mass index is 30 and above,
       they are good candidates for Wegovy."
        
       Not just anyone can take the drug, however.
        
       It must be prescribed by a licensed healthcare professional, like a
       doctor or nurse practitioner.
        
       Girgis also explained that people with a history of thyroid cancer,
       pancreatic or kidney problems, or have serious allergies to
       semaglutide, wouldn't be good candidates for Wegovy. He said the drug
       has 2.4 milligrams of semaglutide in the weekly injectable, compared
       to the 1.0 milligrams in a single Ozempic dose.
        
       **READ MORE: How Wegovy works and reported side effects**
        
       Wegovy is expected to cost patients about $400 a month and it's not
       clear if medical insurance plans will cover it.
        
       Girgis said he's encouraged by what he's seen so far.
        
       "I would say it's too early to see all the insurance companies jumping
       in to cover that for weight loss. But as of yet, I've seen actually
       two insurances that are already covering patients for Wegovy."
        
       Girgis also hopes on-label use of Wegovy will cut down on shortages
       associated with off-label use of Ozempic.
        
        
        
        
       ______________________________________________________________________
                                                 Served by Flask-Gopher/2.2.1